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ABSTRACT 
The female sex hormone estrogen has potent neuroprotective properties. Some of these 
effects may be due to direct modulation of mitochondrial functions. I hypothesized that �­
estradiol, a specific hormone of the estrogen family, will improve mitochondrial bioenergetics in 
ovariectomized mice. Mice (C57BL/6J, female, 4- 10 months-old) were ovariectomized via 
bilateral incision and control animals underwent sham surgery. Ovariectomized mice were 
divided into two groups. One group received a subcutaneous injection of 17-�-estradiol (E2) 
dissolved in com oil (30 ng/g) 24 h prior to synaptosome isolation (estradiol group). The second 
group received com oil alone (OVX). Synaptosomes were isolated from the forebrain by Percoll 
gradient centrifugation. Oxygen consumption of permeabilized synaptosomes was measured 
using Clark-type polarographic electrodes at 37°C. Respiration rates under conditions of 
oxidative phosphorylation (OXPHOS, state 3) were determined in presence of 5 mM pyruvate, 2 
mM malate, 10 mM glutamate, 10 mM succinate, and 2 mM ADP. Our results revealed that 
OXPHOS state 4 rates dropped in OVX mice compared to those receiving the sham surgery. 
Respiration rates after estrogen treatment increased compared to OVX and were 
indistinguishable from those in the sham treatment. However, no differences in OXPHOS rates 
were observed among groups in absence of succinate. My data indicate that E2 directly increases 
mitochondrial activity. Additional studies should attempt to determine whether succinate 
dehydrogenase levels are altered by E2 administration. 
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INTRODUCTION 
Alzheimer's disease (AD) is a neurodegenerative disease affecting 2% of the population 
in the industrialized world (Mattson et al., 2011). AD is characterized by severe dementia, 
extensive memory loss, and other observable mental changes in patients (Dickson et al., 1999). 
The study of AD has led to the inclusion of several physiological changes on the cellular and 
molecular levels that characterize the disease itself (Katzman, 1976). For example, 
neurofibrillary tangles, twisted fragments of protein that clog up the cell, are observed in the 
early stages of the disease. These tangles propagate and cause the formation of senile and 
neuritic plaques, which are clusters of dead and dying nerve cells, glial cells, and protein 
(Tiwari-Woodruff et al., 2007). Dysfunctions of synaptic mitochondria have been shown to play 
a key role in neuronal death, ultimately leading to an increase in plaque levels within brain tissue 
(Nicholls and Budd, 2000; Swerdlow, 2006). As the efficiency of mitochondrial respiration 
declines, less energy becomes available to cells, further aggravating the brain tissue (Castellani 
et al., 2002). In order to combat declining mitochondrial respiration, studies have been conducted 
to determine which compounds can be used to prevent mitochondrial dysfunction entirely, or 
slow the decline in respiratory capacity. To date, one of the most promising compounds is 
estrogen (Green et al., 2001; Simpkins, 2006; Brinton, 2008). 
Beneficial roles of estrogen on brain functions have been extensively studied. Two 
isomers of the estrogen molecule exist, alpha- and 17-�-estradiol (Morin et al., 2002). Alpha­
estradiol is highly concentrated in the brain, and its function is not fully understood. The 
concentration of 17-�-estradiol (E2), however, is fairly constant throughout the majority of the 
body and is most commonly associated with the regulation of the menstrual cycle and the 
development of secondary sexual characteristics in women. In addition, E2 confers 
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neuroprotection and has anti-apoptotic properties in neurons (Simpkins, 2006; Brand and 
Nicholls, 2011). When neuronal cultures were grown in a medium with E2 and compared to 
cultures without E2, neuronal growth and intemeuronal connections drastically increased in the 
culture containing the E2-fortified medium (Fig.I). 
Fig. 1: Mouse neurons grown in cell culture plates. Neurons were grown in absence of 
estrogen (A) and in presence of 0.1 µg E2/mL of cell culture medium (Bar= 100 µm) 
(Sudo et al., 1997). 
Interestingly, E2 can also been shown to assist in the stabilization of the mitochondrial 
membrane potential. Therefore, the mechanisms through which E2 exhibits neuroprotective 
properties might lie within the mitochondria (Hirai et al., 2001). Receptors for both alpha- and 
17-beta-estradiol (ERa and ERb respectively) have been located in mitochondria, where they 
bind to the D-loop of mouse and human mtDNA (mitochondrial DNA) (Chen et al., 2009). There 
is a higher prevalence of ERb receptors due to a mitochondrial targeting sequence in ERb at 
amino acid positions 220-270, a sequence that is absent in ERa (Cheng et al., 2004). Additional 
studies indicate that ERb interaction with the genes Tom70 and Hsp70 may play a role in 
mitochondrial trafficking of ERb (Simpkins, 2006). 
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When mitochondria were isolated from ovariectomized rats that had been treated (in vivo) 
with E2, increased respiration rates were observed ( Irwin et al., 2008). Furthermore, studies on 
the changes in the mitochondrial proteome in rats revealed an increased expression of the 
proteins that link glucose utilization to the TCA cycle, as well as an increased expression in a 
number of electron transport system (ETS) proteins, such as subunits one to four of complex IV 
(Nilsen et al., 2007). In this context, it is important to note that the activity of the ETS is tightly 
linked to ATP production in the cell by oxidative phosphorylation (OXPHOS). The increased 
expression of any component of this system may directly impact overall ATP production in the 
cell. Understanding the process through which ATP production is achieved during OXPHOS is 
important for determining how E2 may ultimately affect the progression of AD. Electrons from 
NADH and F ADH2 enter the respiratory system at complex I and II, respectively. Complexes I, 
III, and IV function as proton pumps, moving protons from the mitochondrial matrix across the 
inner membrane to the intermembrane space. In order for these complexes to pump protons, 
electrons must pass between the complexes via the electron carriers ubiquinone (from complexes 
I and II to complex III) and cytochrome-c (from complexes III to complex IV). The 
accumulation of protons in the intermembrane space leads to a "back pressure" known as the 
proton motive force (PMF). The ATP synthase complex utilizes this force by allowing protons to 
flow back into the mitochondrial matrix, and in the process combines ADP and inorganic 
phosphate to form ATP. This background is the foundation for testing the bioenergetic effects of 
E2 on specific protein complexes. 
Many studies (Nilson and Brinton, 2003; Irwin et al., 2008) used non-synaptic brain 
mitochondria preparations to elucidate the mechanisms behind estrogen-mediated 
neuroprotection in the brain, but this method has limitations (Klinge, 2008). First, the mixture is 
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naturally heterogeneous, because the isolated non-synaptic mitochondria stem from the cells of 
not only neurons, but from glia cells as well. Second, the environment in which the mitochondria 
are incubated after isolation is different from the physiological conditions in vivo, in terms of 
substrate availability (Nicholls and Budd, 2000). To overcome these limitations, isolated nerve 
terminals (synaptosomes) can be used because they maintain functions similar to those of intact 
cells in terms of metabolism, mitochondrial function, plasma membrane excitability, receptors, 
ion channels, and various components of the cellular machinery for exocytosis and the reuptake 
of neurotransmitters (Scott and Nicholls, 1980; Nilson and Brinton, 2003) (Fig. 2). 
dendrites homogenization 
1'yn a ptosome 
cell body 
Fig. 2: Neuronal diagram, incorporating synaptosomal isolation. 
Adapted from piercenet.com 
In this study, synaptic brain mitochondria were isolated from ovariectomized mice treated 
with E2 24 h prior to isolation. Preparations then underwent a series of detailed respiratory 
assays to determine the effects of E2 on specific complexes of the ETS. These assays were 
performed by measuring the oxygen consumption of isolated synaptosmes in the presence of 
specific substrate and inhibitor combinations. The tests were carried out using a high-resolution 
respirometer with various titration schemes. A standard scheme used to measure the respiration 
rates of maximally energized mitochondria is as follows: the titration of the permeabilizing agent 
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digitonin to the synaptosome suspension is followed by the substrates malate, glutamate, 
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Fig. 3: Example Oroboros Oxygraph 2K trace, including titration scheme. 
The left y-axis that scales the blue line is a measure of the oxygen concentration in the 
chamber of the respirometer. The right y-axis corresponds to the red line, the derivative of the 
blue line, measuring the rate at which oxygen in the chamber is consumed. Any increase in the 
red line indicates an increase in mitochondrial respiration. The x-axis is the duration of the 
experiment in minutes. At the onset of every titration scheme, digitonin is used to permeabilize 
the plasma membrane of the synaptosomes, allowing access to the mitochondria for the 
remainder of the experiment. Malate, glutamate, and pyruvate (MGP) are metabolized to 
generate NADH, thereby functioning as complex I substrates, and after their addition a slight 
increase in oxygen consumption is observed. The addition of ADP then enables complex V 
(F0F 1-ATP-synthase) to generate ATP. Addition of ADP allows the backflow of protons into the 
matrix and increases mitochondrial respiration. To maximally energize the mitochondria, 
succinate is added (a complex I I  substrate) and another increase in respiration is observed. In 
order to observe the "leak-respiration," the backflow of protons that does not engage the ATP-
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synthase, oligomycin is added. Oligomycin binds to the ATP-synthase and prevents protons from 
entering the matrix, thus reducing respiration levels to that of an ADP-free environment. 
Antimycin-A is added last, to shut down the ETS by binding to the ubiquinone receptor site of 
complex II I. This allows any non-mitochondrial respiration to be observed and accounted for. 
In the study presented here, I demonstrate that through titration schemes such as these, 
differences in activity were observed in complex II of the ETS after E2 administrations. E2 
ameliorated the decline in respiration induced by ovariectomy, which leads to the removal of 
endogenous estrogen. 
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MATERIALS AND METHODS 
Ovariectomy 
Ovaries were surgically removed from 4-10 month old female wild-type mice 
(C57BL/6J) according to the following procedure. Each mouse received a 40µL injection of 
ketamine intraperitonially to induce sedation. The lower mid-dorsal region was then clipped and 
prepared for aseptic surgery. A 1 cm incision was made along the skin, and after the skin was 
separated a second incision was made halfway down the side of the abdominal wall allowing 
access to the abdominal cavity in the region of the periovarian fat pad. The ovary was isolated 
using tissue forceps to exteriorize the ovarian fat pad, and then excised between the uterine horn 
and fallopian tube. The abdominal and skin incisions were closed using surgical glue and the 
procedure was then repeated for the other side of the subject. 
Treatment Groups 
C57BL/6J mice were randomly divided into three groups. Group 1 (Sham) was 
comprised of mice that had undergone sham ovariectomy surgery in order to test for any possible 
bioenergetic or physiological changes simply as a result of the bilateral incisions. Group 2 mice 
(OVX) underwent ovariectomy, and after two weeks of recovery, received a subcutaneous 
injection of com oil, the solvent used to bring E2 into solution. Group 3 mice were 
ovariectomized, and received a subcutaneous injection of E2 (30 ng/g) after a two-week recovery 
period. 
Synaptic Mitochondrial Isolation 
Brain synaptosomes were isolated 24h post-treatment from all groups. The mouse 
forebrain was removed, washed, and homogenized in an isolation medium (IM) consisting of 
sucrose (225 mM), mannitol (75 mM), EGTA (1 mM), HEPES (5 mM), and 1 g/L BSA adjusted 
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to pH 7.4 with Tris base (Sigma-Aldrich, St. Louis, MO). Tissue subfractionation was achieved 
via centrifugation first at 1300g in IM, and second in a 15/24/40% Percoll gradient at 30, 700 g. 
The remaining tissues consisted of myelin, synaptosomes, and pure mitochondria, in the 
15/24/40% Percoll sections, respectively. The resulting synaptosomal fraction was washed twice 
in IM, and stored on ice until assayed. 
Respirometry 
Respiration was measured at 37°C using 10-20 µL isolated synaptosomes in each 
respiratory chamber of an Oxygraph-2K (OROBOROS Instruments, Innsbruck, Austria). 
Respiration of permeabilized synaptosomes was measured in 2 mL ofMIR05 (110 mM sucrose, 
60 mM potassium lactobionate, 20 mM taurine, 10 mM KH2P04, 3 mM MgC12, 0.5 mM 
EGTA, 0.1 % BSA, 20 mM HEPES-KOH, pH 7.1) before and after addition of inhibitors or 
uncouplers. DATLAB software (OROBOROS Instruments) was used for data analysis and 
acquisition. 
OXPHOS Analysis 
Synaptosomes were permeabilized through the addition of digitonin dissolved in DMSO 
at 10 mg/ml. This concentration was chosen after several titrations with digitonin, and found to 
be sufficient to permeabilize the synaptosome plasma membrane with the lowest possible impact 
on the outer mitochondrial membrane (OMM). At the given digitonin concentration, additional 
injections of digitonin did not increase oxygen flux of adenosine diphosphate (ADP) stimulated 
respiration, and addition of cytochrome-c (10 µg/ml) led to only minor increases in respiration 
rates. 
Three major titration schemes were performed on all treatment groups. The first tested 
complex I and 'membrane leakiness' of the ETS through the addition of malate (2 mM), 
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glutamate (10 mM), and pyruvate (5 mM), after synaptosomes were permeabilized with digitonin 
(10 µg). Maximal respiration of the ETS was then observed after the addition of ADP (3 mM) 
and succinate ( 10 mM). Oxygen consumption after inhibition of mitochondrial respiration was 
recorded in presence of antimycin A (2.5 µM). The second titration scheme compared states 2, 3, 
and 4 respiration through the additions of 2 mM malate, 10 mM glutamate, 5 mM pyruvate, and 
10 mM succinate. To induce oxidative phosphorylation (OXPHOS) 1 mM ADP was added. The 
third titration tested the activity of complex II alone. This was accomplished through the addition 
of rotenone (0.5 µM), followed by succinate, ADP, and oligomycin. Residual oxygen 
consumption (non-mitochondrial respiration) was recorded in all titrations after the addition of 
2.5 µM antimycin A. Sample sizes for each treatment varied from 6-14 because of mouse type 
availability as well as having the time to carry out all titration schemes consecutively. 
Protein Quantification 
Standard Bradford protein assays could not be run on the synaptosome samples because 
of the known interactions of Percoll with the Bradford reagents. Instead a Lowry protein assay 
was used (Lowry et al., 1951). 
Statistical Analysis 
Statistical differences were determined through analysis of variance (ANOV A). 
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RESULTS 
To determine the effect(s) of 17-�-estradiol (E2) on the bioenergetics of the synaptic 
mitochondria, each complex of the electron transport system (ETS) was evaluated. The state 3 
(ADP-stimulated) respiration of complex I in the presence of malate, glutamate, pyruvate, ADP, 
and succinate was reduced in OVX mice (mean± 1 SE, 5.55 ± 0.32 02•s_1• µg-
1 protein; n = 14) 
compared to Sham (7.00 ± 0.28 pmol 02·s-1• µg-1 protein; n = 8, p < 0.05). In addition, after �-
estradiol treatment, state 3 respiration rates were higher (6.96 ± 0.53 02·s-1•µg-1 protein; n = 6, p 
< 0.05) compared to OVX, and were similar to state 3 rates in Sham mice (p > 0.05). In the 
absence of succinate however, no differences among state 3 rates were observed (Fig. 4). 
Figure 4. Oxygen flux of permeabilized synaptosomes of Sham, OVX, and �-estradiol treated mice during 
state 3 (ADP-stimulated OXPHOS) respiration with and without the addition of succinate. Different 
letters indicate values that differ from each other (p < 0.05). 
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After testing maximum (state 3) respiration in the presence of substrates that engage 
complex I, the state 20 or "leak" respiration was measured in order to determine the extent of 
proton backflow from the mitochondrial inter-membrane space to the mitochondrial matrix. 
Similar to state 3 respiration, state 20 (in presence of oligomycin) rates showed a significant 
decrease in OVX treated mice ( 1.18 ± 0.052 02·s-1• µg-1 protein; n = 13) compared to Sham 
(1.5 1 ± 0.043 02·s-1• µg-1 protein; n = 8), and a significant increase above OVX was observed 
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Figure 5. Oxygen flux of permeabilized synaptosomes of Sham, OVX, and �-estradiol treated mice during 
state 2 (leak) respiration (M+G+P+D+S+O). Different letters indicate values that differ from each other 
(p < 0.05). 
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Because of the differences noted in the presence of succinate, a complex II exclusive 
substrate, I decided to assess complex II by itself. For complex I I  of the ETS, the state 2 
respiration in the presence of P-estradiol was higher (1.464 ±0.07 0.043 02·s-1• µg-1 protein; n = 
6) than OVX respiration levels (0.943 ±0.04 0.043 02·s-1• µg-1 protein; n = 6, p < 0.05), which 
were lower than Sham (1.323 ±0.05 0.043 02·s-1• µg-1 protein; n = 6, p < 0.05). State 3 
respiration exhibited similar patterns (Fig. 6). 
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Figure 6. Oxygen flux of permeabilized synaptosomes of Sham, OVX, and P-estradiol treated mice during 
state 2 (Rot+S) respiration. Different letters indicate values that differ from each other (p < 0.05). 
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Complex I state 2o "leak" respiration (measured in the presence of substrates M+G+P) of 
OVX (0.425 ± 0.025 02·s-1• µg-1 protein; n = 14) and Sham (0.402 ± 0.033 02·s-1 • µg-1 protein; n 
= 8) were similar. When treated with P-estradiol, however, state 20 respiration rate increased 
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Figure 7: Oxygen flux of permeabilized synaptosomes of Sham, OVX, and �-estradiol treated mice 
during state 2 respiration (M+G+P). Different letters indicate values that are different from each other (p 
< 0.05). 
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In order to understand how efficient the ETS performed as whole, I determined the 
respiratory control ratio (RCR) for each treatment group. An RCR is a comparison of respiration 
with and without the presence of ADP, thus indicating the overall health of the mitochondria. A 
higher RCR corresponds to better-coupled mitochondria, in regards to how well it utilizes 
substrates in order to ultimately generate ATP. Sham and OVX mice RCR values were similar 
(1 1.0 + 0.29 and 10.6 + 0.41, respectively), but mice treated with P-estradiol had lower values 
(7.9 + 0.36; n = 12-24) (Table 1). 
Table 1. Respiratory control ratios (RCR) of permeabilized synaptosomes isolated from of Sham, OVX, 
and �-estradiol treated mice (mean± SE; n = 12-24). * Indicates statistically significant differences (p < 
0.05). 
Treatment Respiratory Control Ratio 
(RCR) 
Sham 11.0 ± 0.29 
ovx 10.6 ± 0.41 
/J-estradiol 7.9 ± 0.36 * 
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DISCUSSION 
The goal of this study was to determine the effects of �-estradiol (E2) on the 
bioenergetics of synaptic mitochondria. Through E2 injections, synaptosome isolations, and the 
administration of digitonin prior to the titration of substrates and inhibitors, the impact of E2 on 
mitochondrial functions could directly be investigated. Various titration schemes allowed each 
complex of the ETS to be evaluated for changes as a result of the E2 injections. 
With the addition of �-estradiol, an increase in state 3 respiration was observed in 
maximally energized synaptosomes (Fig. 4). This may point to a possible mechanism through 
which reactive oxygen species (ROS) production may be reduced in the presence of estrogen: the 
fact that the inner mitochondrial membrane (IMM) is more permeable in the presence of 
estrogen, or "leaky," might allow a higher backflow of protons from the inter-membrane space to 
the mitochondrial matrix and thereby reduces the mitochondrial membrane potential and the 
amount of toxic ROS production (Smith et al., 2000). 
State 3 respiration in the presence of succinate was higher compared to OVX mice, and 
was similar to Sham mice. The decrease in the respiratory control rate (RCR) of �-estradiol 
treated mice, when compared to OVX or Sham, was unexpected (Table 1 ). Leak was measured 
in highly energized mitochondria however, and leak respiration under low substrate flux might 
be substantially lower (Choi et al., 2009). When viewed in light of the rest of the data, this 
decrease seems confusing. However, a modest decrease in RCR may not necessarily indicate a 
bioenergetic problem considering the state 3 respiration rates remained at or above OVX levels. 
This reduction in RCR may also contribute to the lower ROS production observed in other 
studies with estradiol treatments (Brinton 2008). Typically a higher RCR is favored because it 
means the ETS is functioning at higher efficiency. As the ETS generates ATP, a small amount of 
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ROS is produced in the process. Consequently, a higher RCR might actually produce more ROS 
than a lower RCR. This reinforces the possible mechanism of estrogen-mediated 
neuroprotection. The percent increase in respiration observed after the addition of succinate 
indicates a second possible mechanism through which E2 might confer some neuroprotective 
effects: activity or amount of succinate dehydrogenase, or complex II of the ETS may be 
upregulated in response to the hormone. After the addition of succinate (the substrate of complex 
11), respiration rates in mice treated with E2 increased from OVX levels (Fig. 4,6). None of the 
other ETS complexes showed a change in activity, leading me to hypothesize that the activity of 
complex II within synaptosomes is a relevant target of estradiol-mediated neuroprotection. 
Further tests should be conducted to determine whether estrogen treatment simply 
increases the amount of complex II, or if it increases the activity of the existing complexes. 
Furthermore, additional tests should be conducted to determine whether the amount of ROS 
generated from the ETS decreases after the administration of E2. 
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CONCLUSIONS 
The major conclusions of this study can be summarized as follows: 
(1) Administration of estrogen of at 30 ng/g induced increases in mitochondrial respiration. 
(2) �-estradiol increases "leak" respiration, possibly reducing ROS production in the process. 
(3) The maximal respiration (state 3, OXPHOS) declined after ovariectomy, but was ameliorated 
by the administration of �-estradiol. 
(4) The mechanism through which estrogen-mediated neuroprotective effects occur is most 
likely thought action on complex II, succinate dehydrogenase, of the ETS. 
2 1  
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